Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.24 USD | +1.97% | +6.22% | +45.14% |
May. 31 | Piper Sandler Initiates Immunome With Overweight Rating, $27 Price Target | MT |
May. 21 | Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.27% | 896M | |
+13.15% | 118B | |
+12.77% | 106B | |
-3.97% | 24.28B | |
+1.19% | 21.96B | |
-9.30% | 18.16B | |
-42.12% | 16.37B | |
-17.23% | 15.56B | |
+4.78% | 13.63B | |
+32.27% | 12.27B |
- Stock Market
- Equities
- IMNM Stock
- News Immunome, Inc.
- Immunome Completes Purchase of Antibodies From Atreca